Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | Novel immunotherapy approaches in lymphoma: CAR-T cells, bispecifics & sequencing

In this video, Gloria Iacoboni, MD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, gives an overview of novel immunotherapy approaches in lymphoma, including CAR-T cells and bispecific antibodies. Dr Iacoboni highlights the encouraging results which have been observed with the use of these agents, and further comments on the optimal sequencing of these therapies. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Honoraria and travel support: Novartis, Kite/Gilead, Bristol-Myers Squibb, Abbvie, Autolus, Sandoz, Miltenyi, AstraZeneca.